Psoriasis is a common, chronic, immune-mediated disease manifested in the skin, affecting 2-3% of the population. It appears in early adulthood and is a lifelong condition. Up to 90% of all psoriasis patients have plaque psoriasis, which is characterized by “plaques” of the skin, that are mainly found on the scalp, knees, elbows, trunk, and limbs causing itching and pain. Psoriasis is diagnosed by medical examination and can upon diagnosis be treated accordingly. The first in-line treatments include topical corticosteroids, while severe cases may receive biologics and oral treatments.

Psoriasis is characterized as a dermatological disease where the tissue architecture is being remodeled. The main component of the skin is collagens, which are remodeled as a part of the normal homeostasis of the skin. In psoriasis, there is an imbalance of tissue build-up and tissue breakdown, resulting in a net degradation of the tissue. Protein fingerprint biomarkers can quantify skin tissue turnover directly in a serum sample and serve as a liquid biopsy.

Biomarkers for other dermatology indications

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.